Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/7829 stock hub

TPEX/7829 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TPEX/7829is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3.5B
Taipei Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TPEX/7829
In the news

Latest news · TPEX/7829

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12P50 15.5P75 22.5
Trailing P/En/a
P25 14.4P50 18P75 31.9
ROE-50.6
P25 -16.2P50 0.3P75 9.8
ROIC-30.4
P25 -11.7P50 -0.2P75 8.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TPEX/7829 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
132
Groups with data
10
Currency
TWD
Showing 132 of 132 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

15
MetricValue
Country
Cayman Islands
Country code
TW
Enterprise value
TWD 3.2B
Exchange
Taipei Exchange
Financial currency
TWD
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Last refreshed
2026-05-10
Market cap
TWD 3.5B
Price
TWD 44.15
Price currency
TWD
Sector
Healthcare
Sic
2834
Symbol
tpex/7829
Website
https://yodapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-11.62%
EV Earnings
-7.81x
EV/FCF
-8.99x
FCF yield
-10.09%
P/B ratio
3.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

5
MetricValue
Net Income
TWD -407.2M
ROA
-29.47
ROCE
-39.72
ROE
-50.58
ROIC
-30.38

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Assets
TWD 1B
Cash
TWD 325.4M
Current Assets
TWD 998.6M
Current Liabilities
TWD 30.8M
Debt
TWD 811,000
Debt Equity
TWD 0
Debt FCF
TWD -0
Equity
TWD 984M
Interest Coverage
-15,072
Liabilities
TWD 33.5M
Long Term Assets
TWD 18.9M
Long Term Liabilities
TWD 2.7M
Net Cash
TWD 324.6M
Net Cash By Market Cap
TWD 9.26
Net Cash Growth
-47.84%
Net Debt Equity
TWD -0.33
Tangible Book Value
TWD 975.8M
Tangible Book Value Per Share
TWD 12.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
32.42
Net Working Capital
TWD 643.2M
Quick ratio
10.59
Working Capital
TWD 967.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-85.48%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

32
MetricValue
200-day SMA
52.74
50-day SMA
48.1
50-day SMA vs 200-day SMA
50under200
All Time High
77.6
All Time High Change
-43.11%
All Time High Date
2025-09-02
All Time Low
32.65
All Time Low Change
35.22%
All Time Low Date
2025-07-11
ATR
2.63
Beta1y
0.24
Ch YTD
-24.66
High
44.15
High52
77.6
High52 Date
2025-09-02
High52ch
-43.11%
Low
42
Low52
32.65
Low52 Date
2025-07-15
Low52ch
35.22%
Ma50ch
-8.21%
Price vs 200-day SMA
-16.29%
RSI
42.6
RSI Monthly
0
RSI Weekly
35
Sharpe ratio
0.64x
Sortino ratio
1.48
Total Return
-85.48%
Tr YTD
-24.66
Tr1m
2.67%
Tr1w
0.46%
Tr3m
-28.44%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
TWD -391.9M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
54,919,724%
Net Borrowing
-792,000
Shares Insiders
18.76%
Shares Institutions
0%
Shares Out
79,388,160
Shares Qo Q
0.56%
Shares Yo Y
85.48%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

44
MetricValue
Adjusted FCF
TWD -393.5M
Average Volume
132,421.05x
Bv Per Share
12.4
CAPEX
TWD -389,000
Ch1m
2.67
Ch1w
0.46
Ch3m
-28.44
Ch6m
-29.02
Change
0.68%
Change From Open
0.68
Close
43.85
Days Gap
0
Depreciation Amortization
1,660,000
Dollar Volume
3,070,985.7
Earnings Date
2026-05-13
EBIT
TWD -391.9M
EBITDA
TWD -390.2M
EPS
TWD -5.14
F Score
2
FCF
TWD -353.8M
FCF EV Yield
-11.12x
FCF Per Share
TWD -4.46
Financing CF
727,221,000
Fiscal Year End
December
Founded
2,019
Investing CF
-615,350,000
Is Primary Listing
1
Last Earnings Date
2025-11-27
Last Report Date
2025-12-31
Ma150
55.62
Ma150ch
-20.62%
Ma20
45.84
Ma20ch
-3.68%
Net CF
-243,731,000
Next Earnings Date
2026-05-13
Open
43.85
Position In Range
100
Ppne
3,201,000
Price Date
2026-05-08
Ptbv Ratio
3.59
Relative Volume
0.53x
Share Based Comp
39,731,000
Tr6m
-25.43%
Volume
69,558
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TPEX/7829 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns TPEX/7829?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.0%
Share of float held by funds and institutions
Insider ownership
+18.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+85.5%
Negative means the company is buying back shares.
Technical

TPEX/7829 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
42.6
Neutral momentum band
Price vs 200-day MA
-16.3%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.64
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TPEX/7829

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/7829 stock rating?

tpex/7829 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/7829 analysis?

The full report lives at /stocks/tpex/7829/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/7829?

The latest report frames tpex/7829 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/7829 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

tpex/7829 stock profile: metrics, valuation and analysis | StockMarketAgent.AI